RETATRUTIDE 60

Adjustable dose

Retatrutide AQ – 60 MG / Pen – Apex PHARMA

🧪 Product Type

Advanced Peptide – Triple Receptor Agonist (GLP-1 / GIP / Glucagon)

Active Ingredient: Retatrutide

Concentration: 60 MG / pen

Form: Pre-filled injectable pen (aqueous solution)

Manufacturer: Apex PHARMA

📄 Description

Retatrutide AQ by Apex PHARMA is a next-generation injectable peptide therapy formulated in a ready-to-use prefilled pen, containing 60 MG of Retatrutide in 3 mL of aqueous solution. It functions as a triple receptor agonist, simultaneously targeting:

GLP-1 (Glucagon-like peptide-1)

GIP (Gastric inhibitory peptide)

Glucagon receptors

This unique triple action has demonstrated promising results in metabolic research, especially in obesity management, type 2 diabetes, and energy regulation.

✅ Key Benefits

🔥 Powerful Fat-Burning Potential

Increases metabolic rate and promotes lipolysis

🍽️ Appetite Suppression & Satiety

Helps reduce caloric intake through central appetite regulation

💉 Convenient Pre-Filled Pen

Easy and precise administration without reconstitution

📉 Improved Blood Glucose Control

Enhances insulin sensitivity and lowers fasting glucose

⚙️ Supports Weight Management & Energy Balance

Ideal for research involving complex metabolic disorders

⚙️ Mechanism of Action

Retatrutide mimics multiple gut-derived hormones, activating receptors involved in:

Glucose homeostasis

Fat metabolism

Energy expenditure

Appetite regulation

This synergy helps deliver comprehensive metabolic modulation in experimental models.

💉 Suggested Research Use (For Laboratory Research Only)

Dosage: Varies based on protocol (typically once weekly)

Administration: Subcutaneous injection via prefilled pen

No mixing or preparation required

Monitor for metabolic markers, appetite response, and body composition changes

⚠️ Potential Side Effects

Nausea or mild GI discomfort (usually subsides over time)

Headache or dizziness

Injection site irritation

Temporary fatigue or appetite loss

Side effects are generally dose-dependent and resolve with continued use.

🚫 Contraindications / Exclusion in Research

History or risk of thyroid carcinoma

Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Severe GI disorders

Known hypersensitivity to peptide-based therapies

🛒 Product Information

Product Name: Retatrutide AQ

Dosage: 60 MG in 3 mL solution

Device: Prefilled injection pen

Brand: Apex PHARMA

Intended Use: For Research Purposes Only – Not for Human Consumption

Storage: Refrigerate at 2°C–8°C; do not freeze

Shipping: Available via certified research supply channels

Ozempic weight loss pen

Klikjaro 15 mg TIRZEPATIDE

NAD⁺ 500 mg pen

Retaklik 6 0 m g

Retatrutide 60 mg